Navigation Links
New oral antiviral treatment of cold sores approved

A supplemental new drug application (sNDA) for Valtrex (valacyclovir HCl) caplets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of cold sores in healthy adults. This was announced by GlaxoSmithKline which also added that this new application for Valtrex// makes it the first one-day, oral antiviral medication proven to shorten the duration of a cold sore outbreak.

Cold sores, also known as herpes labialis and commonly referred to as fever blisters, are ulcers or blisters on the lip and outer edges of the mouth caused by the herpes simplex virus. People who develop cold sores are advised to exercise high levels of caution, like washing hands immediately after touching the sore, as they are highly contagious, like other herpes infections. Though, it is estimated that that 20 to 40 per cent of adults develop cold sores at some point in time, it is not clear as to why some people get cold sores while others do not. Several factors like stress, exposure to sun, a cold, fever or flu could trigger the herpes simplex virus, which starts reproducing almost immediately, causing damage to skin cells that could lead to characteristic blisters.

Valtrex, is now, the only drug which offers the convenience of a one-day treatment for cold sores. It is also the only drug which offers the convenience of once-daily dosing for the suppression of genital herpes outbreaks, as well as a three-day treatment for recurrent outbreaks of genital herpes. Treatment with Valtrex is most effective when it is initiated at the first instance of a cold sore and should be administered for more than a day. The efficacy of using Valtrex for treatment after the development of clinical signs of a cold sore has, however, not yet been established.


'"/>




Page: 1

Related medicine news :

1. Catechins in green tea show antiviral effect on influenza virus
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Feeding channel created by malaria parasite - a new target for malaria treatments
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... 2017 , ... Alert Sentry Group LLC., a leader in the Personal Emergency ... iSAFE and the iSAFE Plus. These iSAFE products are the most affordable and most ... and iSAFE Plus offer direct GPS Location and two-way calling with the push of ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. ... will speak to the press on behalf of over 200 doctors, scientists, and scientific ... commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, ...
(Date:3/28/2017)... VA (PRWEB) , ... March 28, 2017 , ... The ... Still, MHA, FRBMA, has begun to serve as its new executive director. Mr. Still ... the Executive Search Committee. , “Bob, as he is known to our members, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning ... will begin serving as new board chair for Orange County health care system ... the remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of two biometric time and attendance tracking products: the new NCheck Cloud Bio ... Cloud Bio Attendance uses biometric face recognition to enable users to check in ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN MATEO, Calif. , March 27, 2017 ... has been acquired by Ethicon, a division of ... Reflux Management System for the treatment of gastro-esophageal ... on magnetic sphincter augmentation (MSA) technology and the ... European medical centers. Torax Medical was ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
Breaking Medicine Technology: